RAMANTAMIG
UNII L97FGF546Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Ramantamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L97FGF546Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2988886-91-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L97FGF546Q

CAS Registry Number

2988886-91-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RAMANTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C216004

National Cancer Institute reference terminology for clinical and research data.

INN ID

13340

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-51

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ramantamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RAMANTAMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA1-SCFVKH_L-LAMBDA2)_SCFVKH-G1(H-CH2-CH3), ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D)) AND ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)), HOMO SAPIENS MONOCLONAL ANTIBODY; TRISPECIFIC, TRIVALENT (RAMANTAMIG)

IMMUNOGLOBULIN G1, TRISPECIFIC, (237-ALANINE,238-ALANINE,268-SERINE,369-SERINE,371-ALANINE,410-VALINE,438-ARGININE,439-PHENYLALANINE), ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL BGCB491 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN G PROTEIN-COUPLED RECEPTOR GPRC5D) (HUMAN MONOCLONAL BGCB491 SINGLE-CHAIN VARIABLE REGION FRAGMENT VL-PEPTIDE LINKER (SYNTHETIC 20-AMINO ACID)-VH), DISULFIDE WITH HUMAN MONOCLONAL BGCB491 .LAMBDA.-CHAIN, (229->263'),(232->266')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN MONOCLONAL BGCB491 SINGLE-CHAIN VARIABLE REGION FRAGMENT VL-PEPTIDE LINKER (SYNTHETIC 20-AMINO ACID)-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (5'-SERINE,19'-ALANINE,20'-ALANINE,50'-SERINE,151'-TRYPTOPHAN) (HUMAN .GAMMA.-1 CHAIN C-REGION C-TERMINAL FRAGMENT)

JNJ 79635322 [WHO-DD]

RAMANTAMIG [INN]

RAMANTAMIG [USAN]